Nature Reviews Clinical Oncology – Hodgkin lymphoma: great progress with room for improvement

Nature Reviews Clinical Oncology, Published online: 10 March 2025; doi:10.1038/s41571-025-01012-2

First-line treatment of advanced-stage classic Hodgkin lymphoma (HL) has successfully entered the era of targeted agents based on results from the phase III German Hodgkin Study Group HD21 and US intergroup S1826 trials.
Although these trials bring about important advances, many uncertainties remain and the outcomes of all patients with HL can be further improved.

Ref: https://www.nature.com/articles/s41571-025-01012-2

Categorias